18,818 Shares in Protalix BioTherapeutics, Inc. (NYSE:PLX) Acquired by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 18,818 shares of the company’s stock, valued at approximately $35,000. Other institutional investors and hedge funds have also added […]
Y Intercept Hong Kong Ltd acquired a new position in Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 18,818 shares of the company’s stock, valued at approximately $35,000. Other institutional investors and hedge funds have also added […]
